Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anidulafungin and Voriconazole in Invasive Aspergillosis
NCT00531479Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 24
01
Overview
A Phase 3 trial of anidulafungin in invasive aspergillosis (IA), sponsored by Pfizer. Started Jul 2008; status: completed.
02
Drugs
anidulafungin
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on NCT00531479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531479.